Establishing secure connection…Loading editor…Preparing document…

Biocompatibility Testing Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

BIOCOMPATIBILITY TESTING REPORT AND SERVICE AGREEMENT

Client Name:   Testing Laboratory:

WHEREAS

WHEREAS, Client Name: desires to obtain biocompatibility testing services for medical device components and related materials described herein; and

WHEREAS, Testing Laboratory agrees to perform specified biocompatibility tests in accordance with recognized standards and methods, and to deliver a written report of findings subject to the terms set forth in this Agreement.

NOW, THEREFORE, the parties agree as follows:

Report Identification

Sample Collection Date:   Date Received by Laboratory:

Tests Performed

The following tests were performed (check all that apply) and documented in the Methods and Results sections:








Methods and Standards

Applicable standards, reference methods, and laboratory-specific procedures used to perform the tests are described below:

Results Summary

Summarized outcomes of performed tests (enter quantitative values, pass/fail, or narrative findings as applicable).

Conclusion

Limitations

The Laboratory's conclusions apply only to the samples tested under the described conditions. Results should not be extrapolated to untested materials or finished devices without written agreement. The Laboratory is not responsible for sample integrity prior to receipt.

Scope of Work

The laboratory shall perform the tests expressly set forth in this Report and any attachments, using validated methods and qualified personnel. The Laboratory will provide a written report containing methods, raw data, results, and interpretation where applicable.

Payment Terms

Fees for testing and reporting services are as set forth below. Client agrees to pay all fees in accordance with this section. Where testing requires additional work or repeats not covered in the initial scope, Client will be notified and additional fees will apply.

Term and Termination

This Agreement commences on the Start Date below and continues until completion of the agreed scope or earlier termination in accordance with this section.

Start Date:

End Date (if applicable):

Either party may terminate for material breach if the breach is not cured within the notice period specified above. Termination does not relieve Client of payment obligations for services performed through the effective date of termination.

Confidentiality

Each party shall treat as confidential all non-public information exchanged under this Agreement, including test methods, raw data, and reports. Confidential information shall not be disclosed to third parties without prior written consent, except as required by law or regulatory authorities. The Laboratory may disclose summary data in aggregate internal metrics provided no Client-identifying information is revealed.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the state or jurisdiction specified below, without regard to conflict of law principles:

Entire Agreement

This document, together with any attachments and purchase orders expressly incorporated herein, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior written or oral agreements. No amendment is effective unless in writing and signed by authorized representatives of both parties.

Certifications and Representations

The Laboratory certifies that tests were performed by qualified personnel using methods described in this report and that all results reflect the Laboratory's findings at the time of testing. The Client represents that the information and samples provided are accurate and that Client has authority to submit samples and accept the terms herein.

Client:

By:

Date:

Testing Laboratory:

By:

Date:

Enter text✕

What a Biocompatibility Testing Report Is and Why It Matters

A Biocompatibility Testing Report documents laboratory evaluations of a medical device, material, or component to determine biological safety and compatibility with human tissue. It summarizes test methods, standards applied (for example ISO 10993 series), results, conclusions, and recommended controls. Regulators, notified bodies, and manufacturing quality teams use the report to support regulatory submissions, CE marking, 510(k) or PMA pathways, risk management files, and clinical study materials. The report establishes traceability from sample to certificate and demonstrates whether material-related hazards require mitigation.

Why a Clear, Complete Report Reduces Regulatory Risk

A well-constructed Biocompatibility Testing Report provides auditable evidence of safety decisions, supports regulatory submissions, and helps align product development with applicable standards. It reduces review cycles and clarifies next-step controls for manufacturing and clinical teams.

Why a Clear, Complete Report Reduces Regulatory Risk

Who Prepares and Relies on This Report

Teams in regulatory affairs, quality assurance, R&D, and clinical affairs commonly create or review biocompatibility reports.

  • Regulatory Affairs — Prepares content for submissions and responds to agency questions about test selection and conclusions.
  • Quality Assurance — Uses results to update risk controls, material specifications, and manufacturing release criteria.
  • R&D / Clinical Teams — Selects test samples, interprets biological relevance, and plans mitigations based on outcomes.

External reviewers, notified bodies, and contract manufacturers also depend on consistent report structure and traceable data to validate decisions.

Essential Sections to Include in Every Report

A professional report follows a consistent structure so reviewers can quickly find methods, conclusions, and traceability information.

Executive Summary

Concise overview of sample identity, tests performed, key results, and final biological safety conclusion for rapid regulatory review and internal stakeholders.

Sample Identification

Detailed description of the device/component, material composition, lot numbers, manufacturing process references, and any finished-device or extract information necessary for traceability.

Test Methods

List of standards and protocols (for example ISO 10993 parts) with laboratory method IDs, acceptance criteria, and deviations documented for reproducibility.

Results and Data

Raw data, summarized findings, statistical analyses, and observed effects presented in tables and figures with units and limits of detection.

Interpretation

Discussion that links test results to biological relevance, risk assessment conclusions, and whether additional testing or controls are required.

Appendices

Chain-of-custody records, certificates of analysis, instrument calibration logs, and lab accreditation statements (for example ISO/IEC 17025).

Required Identification and Administrative Fields

Report Title: Biocompatibility Testing Report
Product ID: Model or catalog number
Sample Details: Material, lot, and collection date
Test Dates: Start and completion dates
Laboratory: Name and accreditation
Author & Approval: Prepared by and authorized signature

Step-by-Step: Completing the Report

Follow a linear workflow from sample receipt through testing, interpretation, and sign-off to ensure traceability and regulatory readiness.

  • 01
    Receive Sample: Record chain of custody and sample condition.
  • 02
    Select Tests: Choose ISO 10993 tests relevant to contact type and duration.
  • 03
    Run Analysis: Execute validated methods and document all raw data.
  • 04
    Interpret & Sign: Complete conclusions, route for review, and obtain approvals.

Configuring an Electronic Workflow for Report Completion

Set up roles, review order, and required fields in your document management system before sending for signatures.

Field Configuration
Author Required; editable until submission
Reviewer Sequential approval; optional comments
Approver Final sign-off; required signature
Attachments Appendices locked after approval

Where to Send the Completed Report

Route the finalized report to stakeholders and regulatory repositories according to internal SOPs and submission needs.

  • Internal QA: Retention copy for quality records.
  • Regulatory Affairs: For filing in 510(k), PMA, or technical dossier.
  • Manufacturing: Update material release and control documents.
  • External Partners: Send to notified bodies or contract manufacturers as needed.

Digital Delivery and Signing Considerations

Choose a platform that preserves audit trails, supports required authentication, and retains records in compliance with regulations.

  • Audit Trail: Record timestamps, IP, and signer identity
  • Authentication: Use email, SMS, or stronger methods
  • File Formats: PDF/A or PDF with embedded certificates

Ensure the chosen system meets any applicable standards such as 21 CFR Part 11 for FDA-regulated records and maintains retention capabilities.

Typical Timelines and Turnaround Expectations

Understand expected durations so planning and regulatory submission schedules align with testing and review cycles.

Sample Receipt to Test Start:

1–7 business days depending on lab backlog

Typical Test Turnaround:

2–8 weeks depending on test complexity

Report Drafting:

2–5 business days after data finalization

Internal Review:

3–10 business days for crossfunctional review

Regulatory Submission Buffer:

Allocate at least 2–4 weeks for responses and corrections

Common Preparation Mistakes to Avoid

  • Incomplete sample traceability: failing to document lot numbers, collection date, or chain of custody can invalidate test results during audits or regulatory review.
  • Incorrect test selection: choosing methods that do not match intended contact type or duration leads to inconclusive safety assessments and may trigger repeat testing.
  • Missing raw data or calibration logs: omitting instrument calibration certificates or raw datasets undermines reproducibility and can delay approvals.
  • Ambiguous conclusions: reporting observations without relating them to biological relevance and risk management decisions confuses reviewers and prolongs remediation.

Regulatory and Commercial Risks of an Incorrect Report

Submission Delays: May cause agency review hold
Clinical Hold: Insufficient safety data can suspend studies
Product Recall: Undetected biocompatibility issues risk recalls
Re-testing Costs: Repeat tests increase program expenses
Reputational Risk: Regulatory findings harm market trust
Legal Exposure: Claims may arise from patient harm

How This Report Differs From Similar Documents

Compare the Biocompatibility Testing Report with related document types to choose the appropriate deliverable for regulatory or internal needs.

Criteria Biocompatibility Testing Report Safety Data Sheet (SDS)
Primary Purpose biological safety evidence hazard communication
Regulatory Focus fda/iso testing osha/reach/clp compliance
Typical Content methods, raw data, interpretation handling, storage, hazards
Use Case 510(k)/technical dossier user and workplace safety

eSignature Vendor Comparison for Report Signing and Distribution

Compare starting price, core capabilities, and compliance posture for eSignature vendors commonly used to sign and distribute laboratory and regulatory reports.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

How to Update or Revise an Existing Report

Use controlled document procedures and versioning so revisions remain auditable and traceable.

01

Identify Change:

Document reason and scope for the revision
02

Assess Impact:

Evaluate affected tests, conclusions, and downstream records
03

Execute Tests:

Run any required confirmatory testing
04

Draft Revision:

Mark version number and redline changes
05

Review & Approve:

Route to stakeholders for documented approval
06

Archive Prior Version:

Retain prior edition per retention policy

Practical Scenarios Where This Report Is Required

Real-world examples illustrate when a Biocompatibility Testing Report is necessary and how it supports product decisions.

Case Study 1

A medical device developer submitted sample extracts for cytotoxicity and sensitization testing

  • Results flagged localized irritation requiring formulation change
  • The report documented remediation and supported a successful 510(k) submission by showing follow-up testing and controls.

Case Study 2

An implantable component showed unexpected leachables in screening assays

  • Additional chemical characterization identified the source as a manufacturing additive
  • The updated report guided material controls and labeling changes that mitigated clinical risk.

Common Questions About Biocompatibility Testing Reports

Answers to frequent questions about acceptability, electronic signatures, lab accreditation, and recordkeeping for biocompatibility reports.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users